CNTX — Context Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $1.74m
- $123.04m
Annual balance sheet for Context Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.341 | 49.6 | 35.5 | 14.4 | 94.4 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.35 | 51.3 | 37.9 | 16 | 97.9 |
| Net Property, Plant And Equipment | — | — | 0.08 | 0.016 | 0.231 |
| Other Long Term Assets | |||||
| Total Assets | 0.467 | 51.3 | 38 | 16.1 | 98.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.55 | 3.03 | 3.21 | 4.19 | 2.75 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.62 | 3.03 | 3.21 | 4.19 | 2.86 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -9.15 | 48.3 | 34.8 | 11.9 | 95.3 |
| Total Liabilities & Shareholders' Equity | 0.467 | 51.3 | 38 | 16.1 | 98.1 |
| Total Common Shares Outstanding |